FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC Deepens Inquiry into Prescription Drug Middlemen
May 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
Federal Trade Commission sues largest drug middlemen for …
Sep 20, 2024 · The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that...
Federal Trade Commission accuses three drug middlemen of …
Sep 21, 2024 · The FTC accused the "Big Three" pharmacy benefit managers (PBMs) — UnitedHealth Group's Optum Rx, CVS Health's Caremark and Cigna's Express Scripts — of "engaging in anticompetitive and unfair...
Pharmacy benefit managers profit at expense of patients and small ... - CNN
Jul 9, 2024 · PBMs, which serve as middlemen in the drug supply chain by negotiating rebates with drug manufacturers on behalf of insurers, large employers and others, could be steering patients to their own...
F.T.C. Slams Middlemen for High Drug Prices - The New York Times
Jul 9, 2024 · The Federal Trade Commission on Tuesday sharply criticized pharmacy benefit managers, saying in a scathing 71-page report that “these powerful middlemen may be profiting by inflating drug costs...
ANALYSIS: FTC to Expand Drug Middlemen Price Hike Fight in 2025
1 day ago · The Federal Trade Commission in September filed an administrative complaint against the three largest pharmacy benefit managers (PBMs) in the US. The FTC alleged that Caremark Rx, Express Scripts, and Zinc Health Services employ anticompetitive rebating practices that have hiked the price of insulin ...
FTC sues the three largest PBMs for allegedly inflating the cost of ...
Sep 20, 2024 · The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S...
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
Sept. 20, 2024. The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit managers, accusing the drug middlemen of inflating insulin...